Epoch Biodesign raised $18.3M in Series A funding to scale up production of their plastic-eating enzymes.
Epoch Biodesign raised $18.3M in Series A funding to scale up production of their plastic-eating enzymes.
03/05/25, 8:45 AM
Location
londonMoney raised
$18.3 million
Industry
biotechnology
consumer goods
health care
Round Type
series a
Epoch Biodesign, a U.K. startup, has secured $18.3 million in Series A funding to scale its production of enzymes that break down plastic waste. Founded in 2019, the company aims to transfer its biorecycling process from labs to a production facility capable of processing 150 tonnes of waste annually.
Company Info
Location
london, england, united kingdom
Additional Info
Epoch’s biorecycling platform unlocks circularity for the toughest-to-recycle materials. Our AI-designed enzymes enable infinite recycling for mixed plastics and textiles at low temperatures. We produce sustainable outputs for use in apparel, automotive, packaging and more.